To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us." -Dr. John Farley

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.

"This is a potentially important breakthrough for the Gynecologic Oncology Group," said John Farley, MD, a gynecologic oncologist in the Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology at the Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, a Dignity Health Member.

This study was initially developed in 2007, with 52 patients enrolled for the Phase II clinical trial between December 2007 and November 2009. Patients were given 50 milligrams of selumetinib orally twice daily. Of those participants, eight had a measurable decrease in tumor size, seven had partial responses and 34 patients saw their tumors stabilize. The findings suggest that inhibitors of the MAPK pathway warrant further investigation in patients with low-grade ovarian cancer.

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us," Dr. Farley said. He added that Phase III of this trial is scheduled to begin in the next few weeks, with that trial to be the "definitive test" before the treatment becomes available to the general population.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Wisconsin's Dem Socialist Candidate for Governor Defends Her Call to 'Cancel Thanksgiving'

New WI Poll Shows Affordability Top Issue, Socialism NOT Popular

Caught in Hypocrisy, Mamdani Backtracks on IDs for Marxist Marts

ICE Arrests Convicted Murderers, Child Predators, and Other Criminal Illegal Aliens

Police Arrest Man at Trump Golf Course and Find Body Armor, 'High-Powered Firearms' and Anti-Trump Messages

ALL IN: Trump-Endorsed Mike Lindell Steps Down as MyPillow CEO to Focus 100% on MN Governor's Race

AP Calls Michigan Primary for El-Sayed, RJC Says Dems Elected 'Most Antisemitic US Senate Candidate in America'

Florida Scores Another Victory for Kids: Court Affirms Constitutionality of State's Ban on Children Attending Sexualized Drag Shows

'I'm Going to Call It a Revival': Forrest Frank Tour Pastor Reports 50,000 Students Saved

Argentina's Javier Milei Just Proposed a Great Idea. Every Government Should Follow His Lead

(Watch): Nick Shirley's New Video Dismantles the Left's Narrative on Ceuta's Migrant Crisis

Trump Admin Cancels 28,000 Trucker Licenses Held by Illegal Aliens Who Can't Read English Proficiently

Fauci Faces Contempt Vote Wednesday Following Tense Senate Appearance

MyGender Dolls: 'It's Basically A Transgender Mr. Potato Head, If Mr. Potato Head Was a Pervert'

Oregon School Counselor Hits Back at Court Ruling Over His Books Celebrating Boys and Girls

Texas to Open the Nation's First Detransition Clinic

Riley Gaines Backs Sophie Cunningham, While WNBA, ESPN Push Trans Agenda

Patricia Heaton Backs 9/11 Families Opposed to Mamdani at 25th Anniversary Memorial

Brave 9/11 Families Want Mamdani Banned From 9/11 Memorial Services (VIDEO)

Christian Activist Beaten by Muslim Mob in Michigan While Police Watch, No Arrests

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor